KaydedilenlerDerginizi ekleyin

Dergiler / Eurasian Journal of Pulmonology / 2019 / Cilt: 21 - Sayı: 2

Characteristics of metachronous second primary lung cancers

Benan ÇAĞLAYAN
Elif TORUN PARMAKSIZ
Sevda ŞENER CÖMERT
Nesrin KIRAL
Ali FİDAN
Coşkun DOĞAN
Banu SALEPÇİ
Sayfa
127–131
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therewas no significant difference in treatment options and survival between the two groups.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIM: In this study, we aimed to investigate the characteristics of metachronous second primarylung cancer (MSPLC) and the differences between primary lung cancer (PLC) and metachronouslung cancer.MATERIALS AND METHODS: Patients diagnosed with lung cancer between January 2014 andDecember 2016 were retrospectively studied.
📊
Temel Bulgular & Veri:In all tests, P 0.05).
💡
Sonuç & Katkı:Therewas no significant difference in treatment options and survival between the two groups.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

AIM: In this study, we aimed to investigate the characteristics of metachronous second primarylung cancer (MSPLC) and the differences between primary lung cancer (PLC) and metachronouslung cancer.MATERIALS AND METHODS: Patients diagnosed with lung cancer between January 2014 andDecember 2016 were retrospectively studied. MSPLC tumor cases and a new diagnosis of PLC wereevaluated. Clinical, radiological, and demographic findings of the two groups, previous histopathologicdiagnosis of MSPLC, histopathologic diagnosis of lung cancer in both groups, stages of treatment, andtreatment history were recorded. All data were analyzed using the Chi‑square, t‑test, Kaplan–Meier,and Log‑rank method. In all tests, P 0.05). The most frequent primary cancers were laryngeal carcinoma (11 cases)in the MSPLC group, with higher age (64 and 61, P = 0.01, respectively). Tumor size was smaller(44 mm and 52 mm, respectively) than the PLC group (P = 0.03). All other characteristics of bothgroups (P > 0.05) and survival were similar (15 months and 17 months, P = 0.87, respectively).CONCLUSION: Among the lung cancers diagnosed in our clinic, 16% were detected as MSPLC.MSPLC group were older than the PLC group and tumor size is lower than the PLC group. Therewas no significant difference in treatment options and survival between the two groups.

🔖

Bu Makaleye Atıf Yap

ÇAĞLAYAN, B., PARMAKSIZ, E. T., CÖMERT, S. Ş., KIRAL, N., FİDAN, A., DOĞAN, C., SALEPÇİ, B. (2022). Characteristics of metachronous second primary lung cancers. Eurasian Journal of Pulmonology, Cilt: 21 - Sayı: 2, 127–131. https://ajindex.com/articles/509661

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Van Leeuwen FE, Travis LB. Second cancers. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer, Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott‑ Williams & Wilkins
  2. p. 2939‑64. 2. Sarıhan S, Gebitekin C, Yerci Ö, Kurt M, Çetintaş SK, Engin K. An evaluation of second primary lung carcinomas based on a case report. J Uludag Univ Med Fac 2004
  3. 47‑52. 3. Olak J, Ferguson MK. Surgical management of metastatic lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, editors. Lung Cancer, Principles and Practice, 1st ed. Philadelphia: Lippincott‑Raven
  4. p. 603‑14. 4. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975
  5. 606‑12. 5. Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 2016
  6. 3075‑86. 6. Lu MS, Chen MF, Huang YK, Liu HP, Tsai YH. Clinical outcome in lung cancer with a second malignancy: The time sequence matters. Medicine (Baltimore) 2016
  7. e5203. 7. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami‑Porta R, et al. The IASLC lung cancer staging project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007
  8. 706‑14. 8. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, et al. Tobacco and cancer: Recent epidemiological evidence. J Natl Cancer Inst 2004
  9. 99‑106. 9. Liu YY, Chen YM, Yen SH, Tsai CM, Perng RP. Multiple primary malignancies involving lung cancer‑clinical characteristics and prognosis. Lung Cancer 2002
  10. 189‑94. 10. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin SB, Sidransky D. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res 1994
  11. 2098‑101. 11. Ryberg D, Lindstedt BA, Zienolddiny S, Haugen A. A hereditary genetic marker closely associated with microsatellite instability in lung cancer. Cancer Res 1995
  12. 3996‑9. 12. Lindstedt BA, Ryberg D, Haugen A. Rare alleles at different VNTR loci among lung‑cancer patients with microsatellite instability in tumours. Int J Cancer 1997
  13. 412‑5. 13. Available from: http://kanser.gov.tr/Dosya/ca_ istatistik/2014‑RAPOR._uzun.pdf. [Last accessed on 2017 Jun 30]. 14. Hofmann HS, Neef H, Schmidt P. Primary lung cancer and extrapulmonary malignancy. Eur J Cardiothorac Surg 2007
  14. 653‑8. 15. Levi F, Randimbison L, Te VC, La Vecchia C. Se